Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00489866 · ClinicalTrials.gov registry record · Phase 2
Aripiprazole Augmentation of Antidepressants in PTSD
A Phase 2 study, sponsored by Durham VA Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT00489866 is a Phase 2 study that has completed, run by Durham VA Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT00489866, a Phase 2 study, has completed, sponsored by Durham VA Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder (PTSD) symptoms, cognitive symptoms, psychotic symptoms, and depressive symptoms in veterans with PTSD.
Interventions
- DRUG Placebo
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-03 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00489866
The ClinicalTrials.gov registry entry for NCT00489866 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Durham VA Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00489866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00489866 about?
NCT00489866 is a clinical study titled "Aripiprazole Augmentation of Antidepressants in PTSD". The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder (PTSD) symptoms, cognitive symptoms, psychotic symptoms, and depressive symptoms in veterans with PTSD.
What is the current status of trial NCT00489866?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2007-03. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00489866?
The interventions under investigation include: Placebo (DRUG), Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00489866?
This trial is sponsored by Durham VA Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.